Date | Name | Title | Type | Security | Shares | Price | Value | Ownership | Reported |
10/10/2023 | Szyman Catherine M. | CVP, Critical Care | Sale | Common Stock | 5k | $72.68 | $363.4k | | 10/10/2023 |
10/10/2023 | Szyman Catherine M. | CVP, Critical Care | Exercise | Employee Stock Option (Right to Acquire) | 5k | $36.75 | $183.8k | | 10/10/2023 |
10/03/2023 | Chopra Daveen | CVP, TMTT | Sale | Common Stock | 8.5k | $70.00 | $595k | | 10/03/2023 |
10/03/2023 | Chopra Daveen | CVP, TMTT | Exercise | Employee Stock Option (Right to Acquire) | 8.5k | $59.26 | $503.7k | | 10/03/2023 |
10/02/2023 | MUSSALLEM MICHAEL A | Director | Sale | Common Stock | 29.4k | $68.84 | $2M | | 10/02/2023 |
10/02/2023 | MUSSALLEM MICHAEL A | Director | Exercise | Employee Stock Option (Right to Acquire) | 29.4k | $36.75 | $1.1M | | 10/02/2023 |
09/29/2023 | Ullem Scott B. | CVP, CFO | Sale | Common Stock | 7.3k | $69.54 | $504.5k | | 09/29/2023 |
09/29/2023 | Ullem Scott B. | CVP, CFO | Exercise | Employee Stock Option (Right to Acquire) | 7.3k | $36.75 | $266.6k | | 09/29/2023 |
08/14/2023 | BOBO DONALD E JR | CVP,Strategy/Corp Development | Sale | Common Stock | 4.5k | $79.30 | $356.8k | | 08/14/2023 |
08/14/2023 | BOBO DONALD E JR | CVP,Strategy/Corp Development | Exercise | Employee Stock Option (Right to Acquire) | 4.5k | $36.75 | $165.4k | | 08/14/2023 |
08/14/2023 | Wood Larry L | Global President TAVR & Surg | Exercise | Employee Stock Option (Right to Acquire) | 6.4k | $45.28 | $290.7k | | 08/14/2023 |
08/14/2023 | Wood Larry L | Global President TAVR & Surg | Sale | Common Stock | 6.4k | $79.30 | $509.2k | | 08/14/2023 |
08/10/2023 | STONE HEISZ LESLIE | Director | Sale | Common Stock | 3.3k | $78.87 | $260.5k | | 08/10/2023 |
08/09/2023 | Szyman Catherine M. | CVP, Critical Care | Sale | Common Stock | 5k | $78.64 | $393.2k | | 08/09/2023 |
08/09/2023 | Szyman Catherine M. | CVP, Critical Care | Exercise | Employee Stock Option (Right to Acquire) | 5k | $36.75 | $183.8k | | 08/09/2023 |
08/07/2023 | MUSSALLEM MICHAEL A | Director | Exercise | Employee Stock Option (Right to Acquire) | 29.4k | $36.75 | $1.1M | | 08/07/2023 |
08/07/2023 | MUSSALLEM MICHAEL A | Director | Sale | Common Stock | 300 | $80.54 | $24.2k | | 08/07/2023 |
08/07/2023 | MUSSALLEM MICHAEL A | Director | Sale | Common Stock | 29k | $79.86 | $2.3M | | 08/07/2023 |
07/14/2023 | BOBO DONALD E JR | CVP,Strategy/Corp Development | Exercise | Employee Stock Option (Right to Acquire) | 3.5k | $36.75 | $128.6k | | 07/14/2023 |
07/14/2023 | BOBO DONALD E JR | CVP,Strategy/Corp Development | Sale | Common Stock | 3.5k | $92.94 | $325.3k | | 07/14/2023 |
07/14/2023 | Wood Larry L | Global President TAVR & Surg | Sale | Common Stock | 8.7k | $92.94 | $804.8k | | 07/14/2023 |
07/14/2023 | Wood Larry L | Global President TAVR & Surg | Exercise | Employee Stock Option (Right to Acquire) | 8.7k | $45.28 | $392.1k | | 07/14/2023 |
07/10/2023 | Szyman Catherine M. | CVP, Critical Care | Sale | Common Stock | 5k | $90.52 | $452.6k | | 07/07/2023 |
07/10/2023 | Szyman Catherine M. | CVP, Critical Care | Exercise | Employee Stock Option (Right to Acquire) | 5k | $36.75 | $183.8k | | 07/07/2023 |
07/07/2023 | Szyman Catherine M. | CVP, Critical Care | Payment of Exercise | Common Stock | 252 | $90.46 | $22.8k | | 07/07/2023 |
07/07/2023 | Lemercier Jean-Luc M | CVP, EMEACLA and JAPAC | Payment of Exercise | Common Stock | 81 | $90.46 | $7.3k | | 07/07/2023 |
07/05/2023 | MUSSALLEM MICHAEL A | Director | Sale | Common Stock | 7.6k | $91.22 | $695.3k | | 07/05/2023 |
07/05/2023 | MUSSALLEM MICHAEL A | Director | Sale | Common Stock | 21.7k | $90.63 | $2M | | 07/05/2023 |
07/05/2023 | MUSSALLEM MICHAEL A | Director | Exercise | Employee Stock Option (Right to Acquire) | 29.4k | $36.75 | $1.1M | | 07/05/2023 |
06/30/2023 | Ullem Scott B. | CVP, CFO | Sale | Common Stock | 7.3k | $93.27 | $676.7k | | 06/30/2023 |
06/30/2023 | Ullem Scott B. | CVP, CFO | Exercise | Employee Stock Option (Right to Acquire) | 7.3k | $36.75 | $266.6k | | 06/30/2023 |
06/01/2023 | MUSSALLEM MICHAEL A | Director | Sale | Common Stock | 5.3k | $83.43 | $442.2k | | 06/01/2023 |
06/01/2023 | MUSSALLEM MICHAEL A | Director | Sale | Common Stock | 5.4k | $85.08 | $459.1k | | 06/01/2023 |
06/01/2023 | MUSSALLEM MICHAEL A | Director | Sale | Common Stock | 18.7k | $84.57 | $1.6M | | 06/01/2023 |
06/01/2023 | MUSSALLEM MICHAEL A | Director | Exercise | Employee Stock Option (Right to Acquire) | 29.4k | $36.75 | $1.1M | | 06/01/2023 |
|